Search

Your search keyword '"Sereno Moyano M"' showing total 21 results
Start Over Author "Sereno Moyano M" Search Limiters Available in Library Collection
21 results on '"Sereno Moyano M"'

1. Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront [FP07.06]

Author

Blanc-Durand, F., Mielgo Rubio, X., Auclin, E., Ponce-Aix, S., Lopez Castro, R., Nadal, E., Planchard, D., Routy, B., Hendriks, L., Sullivan, I., Dempsey, N., Pilotto, S., Aboubakar Nana, Frank, Pinato, D.J., Castonguay, M., Rodriguez, A., Amores, A., Bluthgen, M.V., Duchemann, B., Castellano, P. Cruz, Aguado De La Rosa, C., Sereno Moyano, M., Ruffinelli, J., Lopez, G., Caramella, C., Besse, B., Mezquita, L., 2020 World Conference on Lung Cancer, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, and UCL - (SLuc) Service de pneumologie

Subjects
Pulmonary and Respiratory Medicine, Oncology
Abstract

INTRODUCTION : The Lung Immune Prognostic Index (LIPI) that combines the neutrophils/[leucocytes minus neutrophils] ratio (dNLR) and lactate dehydrogenase (LDH), is associated with outcomes in pretreated advanced NSCLC patients receiving single agent immune checkpoint inhibitors (ICI). However, its role in first line treatment of advanced NSCLC patients has not been explored yet. We assessed the value of baseline LIPI in the first line setting, for ICI-monotherapy, ICI-combination or platinum-based chemotherapy alone (CT). [...]

Published
2021

2. Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront [FP07.06]

Author

UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de pneumologie, Blanc-Durand, F., Mielgo Rubio, X., Auclin, E., Ponce-Aix, S., Lopez Castro, R., Nadal, E., Planchard, D., Routy, B., Hendriks, L., Sullivan, I., Dempsey, N., Pilotto, S., Aboubakar Nana, Frank, Pinato, D.J., Castonguay, M., Rodriguez, A., Amores, A., Bluthgen, M.V., Duchemann, B., Castellano, P. Cruz, Aguado De La Rosa, C., Sereno Moyano, M., Ruffinelli, J., Lopez, G., Caramella, C., Besse, B., Mezquita, L., 2020 World Conference on Lung Cancer, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Service de pneumologie, Blanc-Durand, F., Mielgo Rubio, X., Auclin, E., Ponce-Aix, S., Lopez Castro, R., Nadal, E., Planchard, D., Routy, B., Hendriks, L., Sullivan, I., Dempsey, N., Pilotto, S., Aboubakar Nana, Frank, Pinato, D.J., Castonguay, M., Rodriguez, A., Amores, A., Bluthgen, M.V., Duchemann, B., Castellano, P. Cruz, Aguado De La Rosa, C., Sereno Moyano, M., Ruffinelli, J., Lopez, G., Caramella, C., Besse, B., Mezquita, L., and 2020 World Conference on Lung Cancer

Abstract

INTRODUCTION : The Lung Immune Prognostic Index (LIPI) that combines the neutrophils/[leucocytes minus neutrophils] ratio (dNLR) and lactate dehydrogenase (LDH), is associated with outcomes in pretreated advanced NSCLC patients receiving single agent immune checkpoint inhibitors (ICI). However, its role in first line treatment of advanced NSCLC patients has not been explored yet. We assessed the value of baseline LIPI in the first line setting, for ICI-monotherapy, ICI-combination or platinum-based chemotherapy alone (CT). [...]

Published
2021

4. FP12.01 Circulating Tumor DNA to the Identification of EGFR Positive NSCLC Long-Term Survivors

Author

Franco, F., primary, Serna-Blasco, R., additional, Sanchez-Hernandez, A., additional, De Julian Campayo, M., additional, Giron, C. Garcia, additional, Dómine Gómez, M., additional, Blasco, A., additional, Sanchez, J.M., additional, Oramas, J., additional, Bosch-Barrera, J., additional, Sala, M., additional, Sereno Moyano, M., additional, Ortega Granados, A.L., additional, Chara, L.E., additional, Hernandez, B., additional, Padilla, A., additional, Coves, J., additional, Blanco, R., additional, Balsalobre, J., additional, Mielgo Rubio, X., additional, Bueno, C., additional, Auglyte, M., additional, Calvo, V., additional, Romero, A., additional, and Provencio, M., additional

Published
2021
Full Text
View/download PDF

5. FP07.06 Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.

Author

Blanc-Durand, F., primary, Mielgo Rubio, X., additional, Auclin, E., additional, Ponce-Aix, S., additional, Lopez Castro, R., additional, Nadal, E., additional, Planchard, D., additional, Routy, B., additional, Hendriks, L., additional, Sullivan, I., additional, Dempsey, N., additional, Pilotto, S., additional, Aboubakar, F., additional, Pinato, D.J., additional, Castonguay, M., additional, Rodriguez, A., additional, Amores, A., additional, Bluthgen, M.V., additional, Duchemann, B., additional, Castellano, P. Cruz, additional, Aguado De La Rosa, C., additional, Sereno Moyano, M., additional, Ruffinelli, J., additional, Lopez, G., additional, Caramella, C., additional, Besse, B., additional, and Mezquita, L., additional

Published
2021
Full Text
View/download PDF

6. 1752P Epidemiological analysis of SARS-CoV-2 virus infection in patients with solid tumors: The experience of Infanta Sofía University Hospital (HUIS)

Author

Gomez Raposo, C., primary, Falagán, S., additional, Andreu-Vázquez, C., additional, Thuissard, I.J., additional, García Fernández, C., additional, Aguayo Zamora, C., additional, Jiménez Gordo, A.M., additional, López Gómez, M., additional, Merino Salvador, M., additional, Sandoval, C., additional, Sereno Moyano, M., additional, Zambrana, F., additional, Roa Franco, S., additional, Martín Domínguez, C., additional, Moreno Rubio, J., additional, and Casado, E., additional

Published
2020
Full Text
View/download PDF

7. Spanish registry of thoracic tumors (TTR): Interim analyses of comorbidities, risk associations, personal and family history of cancer

Author

Lopez Castro, R., primary, Lianes, P., additional, Nogueron Martnez, E., additional, Diz Tain, P., additional, Calzas, J., additional, Juan Vidal, O.J., additional, Sereno Moyano, M., additional, Muñoz, M.A., additional, Guillot Morales, M., additional, Capdevila Riera, L., additional, Campillo Fuentes, J.A., additional, Valdivia-Bautista, J., additional, Cobo Dols, M., additional, Paredes Lario, A., additional, Mielgo Rubio, X., additional, Majem Tarruella, M., additional, Martínez, M., additional, Sanchez Torres, J.M., additional, Rubio-Viqueira, B., additional, and Provencio, M., additional

Published
2019
Full Text
View/download PDF

8. SPAZO2 (SOGUG): Outcomes and prognostic significance of IMDC intermediate prognosis subclassification in metastatic renal cell carcinoma (mRCC) in patients treated with 1st-line pazopanib (1stPz)

Author

Valderrama, B.P., primary, Perez Ramirez, S., additional, Rodriguez-Vida, A., additional, González del Alba, A., additional, Mendez Vidal, M.J., additional, Vazquez Estevez, S., additional, Martinez Ortega, E., additional, Virizuela, J.A., additional, Fernández Calvo, O., additional, Hernández Jorge, A., additional, Vazquez Mazon, F.J., additional, Gonzalez Gragera, M.B., additional, Campayo, M., additional, Etxaniz Ulazia, O., additional, Almagro Casado, E., additional, Sereno Moyano, M., additional, Abad Villar, M.T., additional, Suarez Rodriguez, C., additional, Gallardo Diaz, E., additional, and Arranz Arija, J.A., additional

Published
2019
Full Text
View/download PDF

9. P3.01-88 Clinical and Molecular Analysis of Long-Term Survivors with Advanced Non-Small Cell Lung Cancer: A Multicenter Experience in Madrid

Author

Sereno Moyano, M., primary, Falagan, S., additional, Moreno Rubio, J., additional, Álvarez Álvarez, R., additional, Olmedo, M.E., additional, Mielgo, X., additional, Navarro, F., additional, Ramos, R., additional, Enguita, A.B., additional, Benito, A., additional, Cebollero, M., additional, Alemany, I., additional, Castillo, C., additional, Casado, E., additional, and Ponce Aix, S., additional

Published
2018
Full Text
View/download PDF

10. P1.01-69 Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer

Author

Mielgo-Rubio, X., primary, Sereno Moyano, M., additional, Sotelo-Lezama, M., additional, Lopez Castro, R., additional, Rubio-Martínez, J., additional, Velastegui, A., additional, Olier-Garate, C., additional, Falagan, S., additional, Gómez-Barreda, I., additional, Riquelme, A., additional, Cardeña-Gutiérrez, A., additional, Moreno Rubio, J., additional, López, C., additional, Bueno, C., additional, Silva-Ruiz, J., additional, Zhan Zhou, E., additional, and Chara, L., additional

Published
2018
Full Text
View/download PDF

11. Neutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients

Author

Mielgo Rubio, X., primary, Sereno Moyano, M., additional, Chara, L.E., additional, López-Castro, R., additional, Rubio-Martínez, J., additional, Velastegui, A., additional, Olier-Garate, C., additional, Falagán, S., additional, Gómez-Barreda, I., additional, Riquelme, A., additional, Silva-Ruiz, J., additional, Moreno-Rubio, J., additional, López, C., additional, Bueno, C., additional, Cardeña, A., additional, Pérez-Fernández, E., additional, Martí-Castelló, M.P., additional, and Sotelo-Lezama, M.J., additional

Published
2018
Full Text
View/download PDF

12. Efficacy of therapies after progression to up-front docetaxel (D) with androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC)

Author

Gajate Borau, P., primary, Martin Marino, A., additional, Gallegos Sancho, I., additional, Villa Guzman, J.C., additional, Velastegui, A., additional, Alonso Gordoa, T., additional, Castellano, D., additional, Rubio Romero, G., additional, Pinto Marin, A., additional, Villalobos Leon, L., additional, Maximiano Alonso, C., additional, Sotelo-Lezama, M.J., additional, Sereno Moyano, M., additional, Rodríguez, J.F., additional, Perezagua Marin, C., additional, Ballesteros, J., additional, Marrupe Gonzalez, D., additional, Rodriguez Lajusticia, L., additional, Tafalla García, J.J., additional, and Aguado, C., additional

Published
2018
Full Text
View/download PDF

13. GECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC

Author

Majem Tarruella, M., primary, Campillo, J., additional, Grau Béjar, J.F., additional, Carcereny, E., additional, Bernabe Caro, R., additional, Garcia, Y., additional, Artal-Cortes, A., additional, González Cao, M., additional, Lianes, P., additional, Paredes Lario, A., additional, Sereno Moyano, M., additional, Mielgo Rubio, X., additional, Macias, J.A., additional, Provencio Pulla, M., additional, and Rodriguez-Abreu, D., additional

Published
2018
Full Text
View/download PDF

14. MA10.01 Antibiotic Use and PD-1 Inhibitors: Shorter Survival in Lung Cancer, Especially When Given Intravenously. Type of Infection Also Matters

Author

Mielgo-Rubio, X., primary, Chara, L., additional, Sotelo-Lezama, M., additional, Lopez Castro, R., additional, Rubio-Martínez, J., additional, Velastegui, A., additional, Olier-Garate, C., additional, Falagan, S., additional, Gómez-Barreda, I., additional, Bautista-Sanz, P., additional, Silva-Ruiz, J., additional, Moreno Rubio, J., additional, López, C., additional, Cardeña-Gutiérrez, A., additional, Pérez-Fernández, E., additional, and Sereno Moyano, M., additional

Published
2018
Full Text
View/download PDF

15. SPAZO2 (SOGUG): Validation of the international metastatic database consortium (IMDC) prognostic classification for targeted therapies as 2nd-line after 1st-line pazopanib (1stPz) in metastatic renal cell carcinoma (mRC)

Author

Pérez-Valderrama, B., primary, Arranz Arija, J., additional, Chirivella González, I., additional, Anido Herranz, U., additional, Jurado García, J.M., additional, Suarez Rodriguez, C., additional, García Carbonero, I., additional, de Velasco, G., additional, García Domínguez, R., additional, García Marrero, R.D., additional, Gonzalez Del Alba Baamonde, M.A., additional, Molins Palau, C., additional, Lazaro, M.E., additional, Munoz-Langa, J., additional, Martinez Ortega, E., additional, Hernández Jorge, A., additional, Campayo Guillaumes, M., additional, Sereno Moyano, M., additional, Luque Caro, R., additional, and Rodríguez Sánchez, Á., additional

Published
2017
Full Text
View/download PDF

16. 1848P - Spanish registry of thoracic tumors (TTR): Interim analyses of comorbidities, risk associations, personal and family history of cancer

Author

Lopez Castro, R., Lianes, P., Nogueron Martnez, E., Diz Tain, P., Calzas, J., Juan Vidal, O.J., Sereno Moyano, M., Muñoz, M.A., Guillot Morales, M., Capdevila Riera, L., Campillo Fuentes, J.A., Valdivia-Bautista, J., Cobo Dols, M., Paredes Lario, A., Mielgo Rubio, X., Majem Tarruella, M., Martínez, M., Sanchez Torres, J.M., Rubio-Viqueira, B., and Provencio, M.

Published
2019
Full Text
View/download PDF

17. 954P - SPAZO2 (SOGUG): Outcomes and prognostic significance of IMDC intermediate prognosis subclassification in metastatic renal cell carcinoma (mRCC) in patients treated with 1st-line pazopanib (1stPz)

Author

Valderrama, B.P., Perez Ramirez, S., Rodriguez-Vida, A., González del Alba, A., Mendez Vidal, M.J., Vazquez Estevez, S., Martinez Ortega, E., Virizuela, J.A., Fernández Calvo, O., Hernández Jorge, A., Vazquez Mazon, F.J., Gonzalez Gragera, M.B., Campayo, M., Etxaniz Ulazia, O., Almagro Casado, E., Sereno Moyano, M., Abad Villar, M.T., Suarez Rodriguez, C., Gallardo Diaz, E., and Arranz Arija, J.A.

Published
2019
Full Text
View/download PDF

19. 1413P - Neutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients

Author

Mielgo Rubio, X., Sereno Moyano, M., Chara, L.E., López-Castro, R., Rubio-Martínez, J., Velastegui, A., Olier-Garate, C., Falagán, S., Gómez-Barreda, I., Riquelme, A., Silva-Ruiz, J., Moreno-Rubio, J., López, C., Bueno, C., Cardeña, A., Pérez-Fernández, E., Martí-Castelló, M.P., and Sotelo-Lezama, M.J.

Published
2018
Full Text
View/download PDF

20. 823P - Efficacy of therapies after progression to up-front docetaxel (D) with androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC)

Author

Gajate Borau, P., Martin Marino, A., Gallegos Sancho, I., Villa Guzman, J.C., Velastegui, A., Alonso Gordoa, T., Castellano, D., Rubio Romero, G., Pinto Marin, A., Villalobos Leon, L., Maximiano Alonso, C., Sotelo-Lezama, M.J., Sereno Moyano, M., Rodríguez, J.F., Perezagua Marin, C., Ballesteros, J., Marrupe Gonzalez, D., Rodriguez Lajusticia, L., Tafalla García, J.J., and Aguado, C.

Published
2018
Full Text
View/download PDF

21. 895P - SPAZO2 (SOGUG): Validation of the international metastatic database consortium (IMDC) prognostic classification for targeted therapies as 2nd-line after 1st-line pazopanib (1stPz) in metastatic renal cell carcinoma (mRC)

Author

Pérez-Valderrama, B., Arranz Arija, J., Chirivella González, I., Anido Herranz, U., Jurado García, J.M., Suarez Rodriguez, C., García Carbonero, I., de Velasco, G., García Domínguez, R., García Marrero, R.D., Gonzalez Del Alba Baamonde, M.A., Molins Palau, C., Lazaro, M.E., Munoz-Langa, J., Martinez Ortega, E., Hernández Jorge, A., Campayo Guillaumes, M., Sereno Moyano, M., Luque Caro, R., and Rodríguez Sánchez, Á.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results